Loading…

Platinum-Chimeric Carrier Cells for Ultratrace Cell Analysis in Mass Cytometry

Mass cytometry by time-of-flight (CyTOF), a high-dimensional single-cell analysis platform, detects up to 50 biomarkers at single-cell resolution. However, CyTOF analysis of biological samples with a minimal number of available cells or rare cell subsets remains a major technical challenge due to th...

Full description

Saved in:
Bibliographic Details
Published in:Analytical chemistry (Washington) 2023-10, Vol.95 (40), p.14998-15007
Main Authors: Li, Yiyang, Wang, Boqian, Ahmad Khan, Zara, He, Jie, Cheung, Edwin, Su, Wenqiong, Wang, Aiting, Jiang, Hui, Jiang, Lai, Ding, Xianting
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mass cytometry by time-of-flight (CyTOF), a high-dimensional single-cell analysis platform, detects up to 50 biomarkers at single-cell resolution. However, CyTOF analysis of biological samples with a minimal number of available cells or rare cell subsets remains a major technical challenge due to the extensive loss of cells during cell recovery, staining, and acquisition. Here, we introduce a platinum-chimeric carrier cell strategy for mass cytometry profiling of ultratrace cell samples. Cisplatin can rapidly enter broken plasma membranes of dead cells and form a chimeric interaction with cellular proteins, peptides, and amino acids. Thus, 198Pt-cisplatin is adopted to tag carrier cells in the pretreatment stage. We investigated 8 cell lines that are commonly accessible in laboratories for their potential as carrier cells to preserve rare target cells for CyTOF analysis. We designed a panel of 35 protein biomarkers to evaluate the comprehensive single-cell subtype classification capability with or without the carrier cell strategy. We further demonstrated the detection and analysis of as few as 1 Ă— 104 immune cells using our method. The proposed method thus allows CyTOF analysis on precious clinical samples with less abundant cells.
ISSN:0003-2700
1520-6882
DOI:10.1021/acs.analchem.3c02706